Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Health of Hispanic/Latino Workers in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Sociocultural Ancillary Study: Privileges and Disadvantages of Occupational Status and Exposure to Hazards.

Occupational health science·2026
Same author

Clinicians' Decision-Making Preferences Regarding Hypothetical Nanorobotic Applications in Head and Neck Tumors: A Vignette-Based Cross-Sectional Survey.

Cureus·2026
Same author

Platelet triggering receptor expressed on myeloid cells-like transcript 1 regulation in healthy donors and patients at risk of bleeding and thrombosis.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Young onset hypertension - underdiagnosed and undertreated - a rare case presentation.

Journal of family medicine and primary care·2026
Same author

Acute appendicitis complicated by portomesenteric venous thrombosis: A diagnostic and therapeutic challenge - A case report.

Journal of family medicine and primary care·2026
Same author

The Mechanisms and Treatment Approaches of Oxidative Stress and Inflammation in the Development of Chronic Kidney Disease.

Current hypertension reviews·2026

相关实验视频

Updated: May 15, 2025

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
11:54

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Published on: July 13, 2019

8.9K

捐赠者变异性和PD-1表达极限 BK 多重瘤病毒特异性T细胞功能和疗法

Maud Wilhelm1, Amandeep Kaur, Anne Geng

  • 1Transplantation and Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.

Transplantation
|April 9, 2025
PubMed
概括

使用G-Rex培养物优化BK多重瘤病毒特异性T细胞的ex vivo扩张,可以提高细胞数量和细胞毒性. 像 pembrolizumab 这样的免疫检查点抑制剂可以改善 T 细胞功能,并克服 BKPyV 脏病的采用细胞疗法中的供体变异性.

更多相关视频

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.1K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.6K

相关实验视频

Last Updated: May 15, 2025

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
11:54

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Published on: July 13, 2019

8.9K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.1K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.6K

科学领域:

  • 免疫学 免疫学 免疫学
  • 移植医学 移植医学
  • 细胞疗法细胞疗法

背景情况:

  • 乙基多瘤病毒 (BKPyV) 病是造成移植失败的主要原因.
  • 目前的治疗重点是减少免疫抑制以恢复BKPyV特异性免疫力.
  • 活体扩展的T细胞提供了潜力,但由于捐赠者的变异性,其疗效不足于最佳.

研究的目的:

  • 优化BKPyV特异性T细胞的体外扩张协议.
  • 为了比较T细胞扩张的传统和G-Rex培养系统.
  • 评估免疫检查点抑制剂对T细胞功能的影响.

主要方法:

  • 对比BKPyV特异性T细胞的常规和G-Rex扩张培养.
  • 刺激的T细胞与BKPyV池以及评估的细胞因子/细胞毒性反应.
  • 评估了编程细胞死亡蛋白1 (PD-1) 和PD-1连接体1 (PD-1L) 的表达.
  • 评估了pembrolizumab对T细胞反应和细胞毒性的影响.

主要成果:

  • G-Rex培养物比传统培养物产生更高的细胞数量.
  • 扩张的T细胞显示出多功能细胞因子的产生和对BKPyV感染细胞的细胞毒性.
  • 经G-Rex扩展的T细胞显示PD-1表达的增加.
  • 布罗利祖马布降低了PD-1表达,增强了T细胞反应,增加了细胞毒性.

结论:

  • 在ex vivo扩展的T细胞上升调的PD-1有助于供体变异性,并可能限制采用细胞治疗的疗效.
  • 在炎症条件下,BKPyV感染的近管上皮细胞 (RPTEC) 在炎症条件下调节PD-L1.
  • 免疫检查点抑制剂的ex vivo添加值得评估,以加强移植患者的BKPyV特异性T细胞治疗.